Cargando…
Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies
Lung gene therapy for cystic fibrosis disease has not been successful due to several challenges such as the absence of an appropriate vector. Therefore, optimal delivery of emerging therapeutics to airway epithelial cells demands suitable non-viral systems. In this work, we describe the formulation...
Autores principales: | Fernández Fernández, Elena, Santos-Carballal, Beatriz, de Santi, Chiara, Ramsey, Joanne M., MacLoughlin, Ronan, Cryan, Sally-Ann, Greene, Catherine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793620/ https://www.ncbi.nlm.nih.gov/pubmed/29342838 http://dx.doi.org/10.3390/ma11010122 |
Ejemplares similares
-
Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells
por: Vencken, Sebastian, et al.
Publicado: (2019) -
In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
por: Hibbitts, Alan J., et al.
Publicado: (2020) -
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021) -
Effective nebulization of interferon-γ using a novel vibrating mesh
por: Sweeney, Louise, et al.
Publicado: (2019) -
Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)